/

Priovant Therapeutics

Develops and commercializes therapies for severe autoimmune diseases.

BiotechnologyPharmaceuticals priovant.com ↗

Company facts

Founded: 2021
Employees: 90
Headquarters: United States
Type: Private
Funding: Corporate Round · 2022